Variables | CD4 cell increment by >50% | Viral load <1000copy /ml | |||
---|---|---|---|---|---|
N=123, AOR with (95% CI) | P-value | N=152 AOR with (95% CI) |
P-value | ||
Weight category | 3rd-97th centile | 3.22(1.09-6.56) | 0.018 | 3.29(1.91-5.71) | <0.001 |
Sex | Male | 1.02(0.9-1.5) | 0.073 | 1.06(1.14-2.15) | 0.07 |
WHO clinical Staging | I | 4.76(1.53-12.15) | 0.014 | 1.67(1.24-2.24) | <0.001 |
II | 2.08(1.10-5.65) | 0.006 | 1.21(0.92-1.61) | 0.018 | |
Base line CD4 countc | 15-25%/200-500 cell/ml | 4.35(1.47-11.24) | 0.025 | 1.73(1.25-2.40) | <0.001 |
>25%/>500 cell/ml | 1.79(0.56-6.25) | 0.015 | 1.81(1.38-2.38) | <0.001 | |
Aged | <5 years | 2.13(0.81-9.09) | 0.017 | 2.06(1.46-2.91) | <0.001 |
Base line (Hgb)e | >10g/dl | 2.94(1.02-7.14) | 0.014 | 5.88(2.60-13.28 | <0.001 |
Weight gain(%) at three month of ARTf | >10% | 2.5(1.3-4.9) | 0.012 | 11.32(7.37-17.40) | <0.001 |
Weight gain(%) at six month of ARTf | >10% | 4.23(2.12-7.2) | <0.001 | 3.39(1.92-5.72) | <0.001 |
Chronic diarrhea | No | 2.56(0.69-7.25) | 0.007 | 1.76(1.14-2.15) | 0.005 |
ART regimen | NVP+AZT+3TC | 1.05(1.045-2.5) | 0.086 | 1.07(1.24-2.24) | 0.12 |